Co-Diagnostics
CODX
11 hedge funds and large institutions have $778K invested in Co-Diagnostics in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
10% more funds holding
Funds holding: 10 → 11 (+1)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.17% less ownership
Funds ownership: 0.36% → 0.19% (-0.17%)
60% less capital invested
Capital invested by funds: $1.92M → $778K (-$1.14M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$186K |
| 2 |
Barclays
London,
United Kingdom
|
+$17.3K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$14K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$5.96K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$1.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$559K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$461K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$4.67K |
| 4 |
FIA
FNY Investment Advisers
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $281K | +$186K | +6,656 | +142% |
|
|
SM
2
Sabby Management
Miami Beach,
Florida
| $225K | -$461K | -16,458 | -64% |
|
|
3
HighTower Advisors
Chicago,
Illinois
| $107K | +$14K | +500 | +13% |
|
|
CH
4
CVI Holdings
Wilmington,
Delaware
| $90K | -$559K | -19,975 | -85% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $39K | – | – | – |
|
|
6
Barclays
London,
United Kingdom
| $15K | +$17.3K | +617 | New |
|
|
7
Bank of Montreal
Toronto,
Ontario, Canada
| $8K | -$4.67K | -167 | -33% |
|
|
8
UBS Group
Zurich,
Switzerland
| $6K | +$5.96K | +213 | +453% |
|
9
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $4K | – | – | – |
|
|
AG
10
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
|
11
Bank of America
Charlotte,
North Carolina
| $1K | +$1.2K | +43 | New |
|
|
FIA
12
FNY Investment Advisers
New York
| – | -$3K | -117 | Closed |
|
CODX Hedge Fund Activity: Q2 2019 in Review
11 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2019, worth a combined $778K — down 60% from $1.92M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CODX positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Vanguard Group, adding an estimated $186K. The largest seller was CVI Holdings, cutting an estimated $559K.
- 11 institutional investors held Co-Diagnostics (CODX) as of Q2 2019, up from 10 in Q1 2019.
- Funds reported $778K of Co-Diagnostics stock for Q2 2019, down 60% quarter-over-quarter.
- 2 funds opened new Co-Diagnostics positions in Q2 2019 and 1 closed out, a net change of +1 holder.
- The largest Co-Diagnostics buyer in Q2 2019 was Vanguard Group, an estimated $186K added.
- The largest Co-Diagnostics seller in Q2 2019 was CVI Holdings, an estimated $559K sold.
Based on aggregated 13F filings for Q2 2019.